Literature DB >> 19498431

Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas.

David Schiff1, Benjamin W Purow.   

Abstract

Most grade II and grade III gliomas, as well as the secondary glioblastomas that arise from these tumors, possess point mutations that affect the substrate binding site of isocitrate dehydrogenase. These mutations are essentially unique to gliomas, seem to represent an early step in gliomagenesis, and confer a favorable prognosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19498431     DOI: 10.1038/nrneurol.2009.57

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  6 in total

1.  Analysis of the IDH1 codon 132 mutation in brain tumors.

Authors:  Jörg Balss; Jochen Meyer; Wolf Mueller; Andrey Korshunov; Christian Hartmann; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2008-11-05       Impact factor: 17.088

Review 2.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 3.  Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.

Authors:  David Schiff; Paul D Brown; Caterina Giannini
Journal:  Neurology       Date:  2007-09-25       Impact factor: 9.910

4.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

5.  Metabolic enzymes as oncogenes or tumor suppressors.

Authors:  Craig B Thompson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

6.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

  6 in total
  3 in total

1.  Gene expression profiles linked to AT1 angiotensin receptors in the kidney.

Authors:  Natalia A Makhanova; Steven D Crowley; Robert C Griffiths; Thomas M Coffman
Journal:  Physiol Genomics       Date:  2010-08-31       Impact factor: 3.107

2.  Ten-Eleven Translocation-2 gene mutations: A potential new molecular marker in malignant gliomas (Review).

Authors:  Lei Yu; Songtao Qi
Journal:  Oncol Lett       Date:  2011-10-18       Impact factor: 2.967

3.  Rapid determination of tricarboxylic acid cycle enzyme activities in biological samples.

Authors:  Sergio Goncalves; Vincent Paupe; Emmanuel P Dassa; Jean-Jacques Brière; Judith Favier; Anne-Paule Gimenez-Roqueplo; Paule Bénit; Pierre Rustin
Journal:  BMC Biochem       Date:  2010-01-28       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.